跳至主要内容
临床试验/JPRN-jRCTs042220149
JPRN-jRCTs042220149招募中3 期

A randomized controlled trial comparing ERCP-BD versus EUS-HGAS as the first line palliative drainage for malignant biliary obstruction

Sato Junya0 个研究点目标入组 46 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • (1) the presence of a malignant obstruction (=>2cm distal to the hilum)
  • (2) a malignant biliary obstruction with pathologic or radiologic diagnosis
  • (3) the statement of unresectable comfarmed by radiologic diagnosis or characteristics of patient (comorbidities or age)
  • (4) Jaundice: serum total bilirubin =>2.0mg/dL or liver damage: at least 2 of liver
  • enzymes (AST, ALT, ALP, or gamma-GTP) at least 2 times above the upper limit of
  • (5) Eastern Cooperative Oncology Group performance status 0-2
  • (6) age =>18 years old

排除标准

  • (1) a hilar biliary obstruction classificated Bismuth II or more
  • (2) surgically altered anatomy of the stomach and the duodenum except Billroth I
  • (3) history of choledochojejunostomy
  • (4) vomiting and duodenal obstruction with radiologic diagnosis
  • (5) previously performed duodenal stenting
  • (6) less diameter of left intrahepatic bile duct (=<2mm)
  • (7) plateler count <50000 or prothrombin time international normalized ratio =>1.5
  • (8) impossibility in discontinuation of antithrombotic therapy
  • (9) the presence of massive ascites
  • (10) life expectancy less than 3 months
  • (11) other reasons for unsuitable statement to participate the study judged from principal investigator

研究者

发起方
Sato Junya

相似试验